TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biorega AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
20
|
36
|
3 |
| Financial expenses |
2
|
0
|
0 |
| Earnings before taxes |
113
|
396
|
-1 |
| EBITDA |
-3
|
-13
|
-1 |
| Total assets |
372
|
501
|
125 |
| Current assets |
339
|
501
|
17 |
| Current liabilities |
7
|
40
|
59 |
| Equity capital |
364
|
460
|
65 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
97.8%
|
91.8%
|
52.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
565.0%
|
1100%
|
-33.3% |
| Return on assets (ROA) |
30.9%
|
79.0%
|
-0.8% |
| Current ratio |
4842.9%
|
1252.5%
|
28.8% |
| Return on equity (ROE) |
31.0%
|
86.1%
|
-1.5% |
| Change turnover |
-15
|
34
|
3 |
| Change turnover % |
-44%
|
1203% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.